Core outcome measures for chronic pain clinical trials: IMMPACT recommendations

被引：2831

作者：

Dworkin, RH ^{[1
]}

Turk, DC

Farrar, JT

Haythornthwaite, JA

Jensen, MP

Katz, NP

Kerns, RD

Stucki, G

Allen, RR

Bellamy, N

Carr, DB

Chandler, J

Cowan, P

Dionne, R

Galer, BS

Hertz, S

Jadad, AR

Kramer, LD

Manning, DC

Martin, S

McCormick, CG

McDermott, MP

McGrath, P

Quessy, S

Rappaport, BA

Robbins, W

Robinson, JP

Rothman, M

Royal, MA

Simon, L

Stauffer, JW

Stein, W

Tollett, J

Wernicke, J

Witter, J

机构：

[1] Univ Rochester, Sch Med & Dent, Dept Anesthesiol, Rochester, NY 14642 USA

[2] Univ Washington, Seattle, WA 98195 USA

[3] Univ Penn, Philadelphia, PA 19104 USA

[4] Johns Hopkins Univ, Baltimore, MD 21218 USA

[5] Harvard Univ, Boston, MA 02115 USA

[6] Yale Univ, New Haven, CT USA

[7] Univ Munich, D-80539 Munich, Germany

[8] AstraZeneca, Wilmington, DE USA

[9] Univ Queensland, Brisbane, Qld, Australia

[10] Tufts Univ, Boston, MA 02111 USA

[11] Merck & Co Inc, Blue Bell, PA USA

[12] Amer Chron Pain Assoc, Rocklin, CA USA

[13] Natl Inst Dent & Craniofacial Res, Bethesda, MD USA

[14] Endo Pharmaceut Inc, Chadds Ford, PA USA

[15] US FDA, Rockville, MD 20857 USA

[16] Univ Toronto, Hlth Network, Toronto, ON, Canada

[17] Purdue Pharma, Stamford, CT USA

[18] Novartis Pharmaceut, E Hanover, NJ USA

[19] Pfizer Global Res & Dev, Ann Arbor, MI USA

[20] NINDS, Bethesda, MD 20892 USA

[21] Univ Rochester, Rochester, NY 14627 USA

[22] Dalhousie Univ, Halifax, NS B3H 3J5, Canada

[23] GlaxoSmithKline, Res Triangle Pk, NC USA

[24] NeurogesX, San Carlos, CA USA

[25] Johnson & Johnson Consumer Prod Inc, Raritan, NJ USA

[26] Elan Pharmaceut, San Diego, CA USA

[27] Abbott Labs, Lake Forest, IL USA

[28] Univ Calif San Diego, San Diego, CA 92103 USA

[29] US Dept Vet Affairs, Washington, DC USA

[30] Eli Lilly & Co, Indianapolis, IN 46285 USA

来源：

PAIN | 2005年 / 113卷 / 1-2期

关键词：

D O I：

10.1016/j.pain.2004.09.012

中图分类号：

R614 [麻醉学];

学科分类号：

100217 ;

摘要：

[No abstract available]

引用

页码：9 / 19

页数：11

共 50 条

[1] Core outcome domains for chronic pain clinical trials: IMMPACT recommendations
Turk, DC
Dworkin, RH
Allen, RR
Bellamy, N
Brandenburg, N
Carr, DB
Cleeland, C
Dionne, R
Farrar, JT
Galer, BS
Hewitt, DJ
Jadad, AR
Katz, NP
Kramer, LD
Manning, DC
McCormick, CG
McDermott, MP
McGrath, P
Quessy, S
Rappaport, BA
Robinson, JP
Royal, MA
Simon, L
Stauffer, JW
Stein, W
Tollett, J
Witter, J
[J]. PAIN, 2003, 106 (03) : 337 - 345
[2] Developing patient-reported outcome measures for pain clinical trials: IMMPACT recommendations
Turk, Dennis C.
Dworkin, Robert H.
Burke, Laurie B.
Gershon, Richard
Rothman, Margaret
Scott, Jane
Allen, Robert R.
Atkinson, J. Hampton
Chandler, Julie
Cleeland, Charles
Cowan, Penny
Dimitrova, Rozalina
Dionne, Raymond
Farrar, John T.
Haythornthwaite, Jennifer A.
Hertz, Sharon
Jadad, Alejandro R.
Jensen, Mark P.
Kellstein, David
Kerns, Robert D.
Manning, Donald C.
Martin, Susan
Max, Mitchell B.
McDermott, Michael P.
McGrath, Patrick
Moulin, Dwight E.
Nurmikko, Turo
Quessy, Steve
Raja, Srinivasa
Rappaport, Bob A.
Rauschkolb, Christine
Robinson, James P.
Royal, Mike A.
Simon, Lee
Stauffer, Joseph W.
Stucki, Gerold
Tollett, Jane
von Stein, Thorsten
Wallace, Mark S.
Wernicke, Joachim
White, Richard E.
Williams, Amanda C.
Witter, James
Wyrwich, Kathleen W.
[J]. PAIN, 2006, 125 (03) : 208 - 215
[3] Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations
Edwards, Robert R.
Dworkin, Robert H.
Turk, Dennis C.
Angst, Martin S.
Dionne, Raymond
Freeman, Roy
Hansson, Per
Haroutounian, Simon
Arendt-Nielsen, Lars
Attal, Nadine
Baron, Ralf
Brell, Joanna
Bujanover, Shay
Burke, Laurie B.
Carr, Daniel
Chappell, Amy S.
Cowan, Penney
Etropolski, Mila
Fillingim, Roger B.
Gewandter, Jennifer S.
Katz, Nathaniel P.
Kopecky, Ernest A.
Markman, John D.
Nomikos, George
Porter, Linda
Rappaport, Bob A.
Rice, Andrew S. C.
Scavone, Joseph M.
Scholz, Joachim
Simon, Lee S.
Smith, Shannon M.
Tobias, Jeffrey
Tockarshewsky, Tina
Veasley, Christine
Versavel, Mark
Wasan, Ajay D.
Wen, Warren
Yarnitsky, David
[J]. PAIN, 2016, 157 (09) : 1851 - 1871
[4] Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations
Edwards, Robert R.
Dworkin, Robert H.
Turk, Dennis C.
Angst, Martin S.
Dionne, Raymond
Freeman, Roy
Hansson, Per
Haroutounian, Simon
Arendt-Nielsen, Lars
Attal, Nadine
Baron, Ralf
Brell, Joanna
Bujanover, Shay
Burke, Laurie B.
Carr, Daniel
Chappell, Amy S.
Cowan, Penney
Etropolski, Mila
Fillingim, Roger B.
Gewandter, Jennifer S.
Katz, Nathaniel P.
Kopecky, Ernest A.
Markman, John D.
Nomikos, George
Porter, Linda
Rappaport, Bob A.
Rice, Andrew S. C.
Scavone, Joseph M.
Scholz, Joachim
Simon, Lee S.
Smith, Shannon M.
Tobias, Jeffrey
Tockarshewsky, Tina
Veasley, Christine
Versavel, Mark
Wasan, Ajay D.
Wen, Warren
Yarnitsky, David
[J]. PAIN REPORTS, 2021, 6 (01) : E896
[5] Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations
Dworkin, Robert H.
Turk, Dennis C.
Wyrwich, Kathleen W.
Beaton, Dorcas
Cleeland, Charles S.
Farrar, John T.
Haythornthwaite, Jennifer A.
Jensen, Mark P.
Kerns, Robert D.
Ader, Deborah N.
Brandenburg, Nancy
Burke, Laurie B.
Cella, David
Chandler, Julie
Cowan, Penny
Dimitrova, Rozalina
Dionne, Raymond
Hertz, Sharon
Jadad, Alejandro R.
Katz, Nathaniel P.
Kehlet, Henrik
Kramer, Lynn D.
Manning, Donald C.
McCormick, Cynthia
McDermott, Michael P.
McQuay, Henry J.
Patel, Sanjay
Porter, Linda
Quessy, Steve
Rappaport, Bob A.
Rauschkolb, Christine
Revickl, Dennis A.
Rothman, Margaret
Schmader, Kenneth E.
Stacey, Brett R.
Stauffer, Joseph W.
Von Stein, Thorsten
White, Richard E.
Witter, James
Zavislc, Stojan
[J]. JOURNAL OF PAIN, 2008, 9 (02): : 105 - 121
[6] Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations
Dworkin, Robert H.
Turk, Dennis C.
Peirce-Sandner, Sarah
Burke, Laurie B.
Farrar, John T.
Gilron, Ian
Jensen, Mark P.
Katz, Nathaniel P.
Raja, Srinivasa N.
Rappaport, Bob A.
Rowbotham, Michael C.
Backonja, Misha-Miroslav
Baron, Ralf
Bellamy, Nicholas
Bhagwagar, Zubin
Costello, Ann
Cowan, Penney
Fang, Weikai Christopher
Hertz, Sharon
Jay, Gary W.
Junor, Roderick
Kerns, Robert D.
Kerwin, Rosemary
Kopecky, Ernest A.
Lissin, Dmitri
Malamut, Richard
Markman, John D.
McDermott, Michael P.
Munera, Catherine
Porter, Linda
Rauschkolb, Christine
Rice, Andrew S. C.
Sampaio, Cristina
Skljarevski, Vladimir
Sommerville, Kenneth
Stacey, Brett R.
Steigerwald, Ilona
Tobias, Jeffrey
Trentacosti, Ann Marie
Wasan, Ajay D.
Wells, George A.
Williams, Jim
Witter, James
Ziegler, Dan
[J]. PAIN, 2012, 153 (06) : 1148 - 1158
[7] Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendations
Gewandter, Jennifer S.
Dworkin, Robert H.
Turk, Dennis C.
Farrar, John T.
Fillingim, Roger B.
Gilron, Ian
Markman, John D.
Oaklander, Anne Louise
Polydefkis, Michael J.
Raja, Srinivasa N.
Robinson, James P.
Woolf, Clifford J.
Ziegler, Dan
Ashburn, Michael A.
Burke, Laurie B.
Cowan, Penney
George, Steven Z.
Goli, Veeraindar
Graff, Ole X.
Iyengar, Smriti
Jay, Gary W.
Katz, Joel
Kehlet, Henrik
Kitt, Rachel A.
Kopecky, Ernest A.
Malamut, Richard
McDermott, Michael P.
Palmer, Pamela
Rappaport, Bob A.
Rauschkolb, Christine
Steigerwald, Ilona
Tobias, Jeffrey
Walco, Gary A.
[J]. PAIN, 2015, 156 (07) : 1184 - 1197
[8] Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations
Dworkin, Robert H.
Turk, Dennis C.
Peirce-Sandner, Sarah
Baron, Ralf
Bellamy, Nicholas
Burke, Laurie B.
Chappell, Amy
Chartier, Kevin
Cleeland, Charles S.
Costello, Ann
Cowan, Penney
Dimitrova, Rozalina
Ellenberg, Susan
Farrar, John T.
French, Jacqueline A.
Gilron, Ian
Hertz, Sharon
Jadad, Alejandro R.
Jay, Gary W.
Kalliomaki, Jarkko
Katz, Nathaniel P.
Kerns, Robert D.
Manning, Donald C.
McDermott, Michael P.
McGrath, Patrick J.
Narayana, Arvind
Porter, Linda
Quessy, Steve
Rappaport, Bob A.
Rauschkolb, Christine
Reeve, Bryce B.
Rhodes, Thomas
Sampaio, Cristina
Simpson, David M.
Stauffer, Joseph W.
Stucki, Gerold
Tobias, Jeffrey
White, Richard E.
Witter, James
[J]. PAIN, 2010, 149 (02) : 177 - 193
[9] Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations
Dworkin, Robert H.
Turk, Dennis C.
McDermott, Michael P.
Peirce-Sandner, Sarah
Burke, Laurie B.
Cowan, Penney
Farrar, John T.
Hertz, Sharon
Raja, Srinivasa N.
Rappaport, Bob A.
Rauschkolb, Christine
Sampaio, Cristina
[J]. PAIN, 2009, 146 (03) : 238 - 244
[10] Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendations
Gewandter, Jennifer S.
Dworkin, Robert H.
Turk, Dennis C.
Farrar, John T.
Fillingim, Roger B.
Gilron, Ian
Markman, John D.
Oaklander, Anne Louise
Polydefkis, Michael J.
Raja, Srinivasa N.
Robinson, James P.
Woolf, Clifford J.
Ziegler, Dan
Ashburn, Michael A.
Burke, Laurie B.
Cowan, Penney
George, Steven Z.
Goli, Veeraindar
Graff, Ole X.
Iyengar, Smriti
Jay, Gary W.
Katz, Joel
Kehlet, Henrik
Kitt, Rachel A.
Kopecky, Ernest A.
Malamut, Richard
McDermott, Michael P.
Palmer, Pamela
Rappaport, Bob A.
Rauschkolb, Christine
Steigerwald, Ilona
Tobias, Jeffrey
Walco, Gary A.
[J]. PAIN REPORTS, 2021, 6 (01)

← 1 2 3 4 5 →